Alta Semper Capital, a London-based private equity firm specializing in healthcare and consumer investments, has successfully raised $57.5 million in commitments for its latest vehicle, Alta Semper Growth Fund II. This milestone underscores the firm’s mission to scale businesses that deliver affordable, high-quality healthcare and consumer products across Africa and other emerging markets.
The fund attracted strong backing from leading development finance institutions. The European Investment Bank (EIB) Group, which includes both the European Investment Bank and the European Investment Fund, committed $37.5 million, while the International Finance Corporation (IFC) pledged $20 million. These commitments represent a significant endorsement of Alta Semper’s investment strategy and impact-driven approach.
Alta Semper Growth Fund II is targeting a total fund size of $150 million. The fund is designed to accelerate growth in sectors that improve access to essential services, with a particular emphasis on:
- Primary healthcare and preventative medicine
- Diagnostics and medical devices
- Digital health solutions
- Consumer wellness platforms
- Disruptive technologies that enhance affordability and efficiency
Capital from the new fund is already being deployed into high-impact businesses. Notable investments include:
- MYDAWA, a leading digital health platform in East Africa that improves access to medicines and health services.
- Allmed Group, a medical device manufacturer specializing in blood purification and renal care solutions.
Afsane Jetha, Managing Partner and CEO of Alta Semper, commented:
Securing commitments from the EIB Group and IFC is a strong validation of our strategy and track record. These partnerships enhance our ability to scale high-quality healthcare and consumer businesses, accelerate technology adoption, and deepen our impact on the ground. Our ambition is to build resilient, equitable, and future-proof health ecosystems that deliver meaningful outcomes for communities while generating attractive returns for investors.
